Evommune EVMN
NYSE EVMN
$7.19 -1.07 (-12.95%)
As of: Oct 1, 2026 · 3:59 PM EDT

Evommune (EVMN) Net Equity Issued and Repurchased (2024 - 2026)

Updated

Evommune (EVMN) posted Net Equity Issued and Repurchased of -$58,000 for Q2 2026, compared with $65.23 million a year earlier.

Analysis

Evommune (EVMN) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Evommune was $209.2 million; for FY2025, it came in at $157.28 million, up 215.6% from FY2024.

  • In prior years, Evommune's Net Equity Issued and Repurchased was $49.83 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Evommune 299.69 Mn -337.83 Mn - -58,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -58,000.00
Mar 31, 2026 117.20 Mn
Dec 31, 2025 92.06 Mn
Jun 30, 2025 65.23 Mn
Mar 31, 2025 2,000.00
Dec 31, 2024 49.83 Mn
API Access

Evommune Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EVMN&period=max&api_key=YOUR_API_KEY